Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood
Go back to Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood| Bruker Corporation (NASDAQ: BRKR) | Delayed: 61.39 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.39 | 52 Week High | $29.85 | |||
| Open | $61.39 | 52 Week Low | $19.59 | |||
| Day High | $61.39 | P/E | 127.90 | |||
| Day Low | $61.39 | EPS | $0.48 | |||
| Volume | 442 | |||||
